REG - Spire Healthcare Grp - Change in Spire Healthcare's directors

Spire HealthcareAnnouncement

06/03/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250306:nRSF5347Za&default-theme=true

RNS Number : 5347Z  Spire Healthcare Group PLC  06 March 2025

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Change in Spire Healthcare's directors

 

6 March 2025

 

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group
in the UK, today announces that, having completed over 10 years of service,
Professor Dame Janet Husband has decided to step down from the Board at the
Company's annual general meeting on 14 May 2025 and will not seek re-election
by shareholders. The Company is pleased to announce the following
Non-Executive Director appointments effective as of today.

 

Non-Executive Director appointments

 

Sir David Sloman will join as a non-independent Non-Executive Director. Sir
David will become a member of the Company's Clinical Governance and Safety
Committee on appointment and will replace Dame Janet as chair on 14 May 2025.
He will also take on the role of Vice Chair from this date.

 

Sir David has had a long career in healthcare management, predominantly in the
NHS. He has held several CEO roles at several NHS trusts, including the Royal
Free London NHS Foundation Trust, the Whittington Hospital NHS Trust and NHS
Haringey Trust. During December 2021 and August 2023, he was the COO of NHS
England, where he was responsible for overseeing all NHS operational delivery,
including the response to the COVID-19 pandemic. Sir David is a non-executive
director of AXA UK and Ireland, a board member of Health Data Research UK, a
fellow of the Royal Society of Medicine, a senior fellow of the Institute for
Healthcare Improvement and a trustee of the Royal College of Radiologists. As
a result of Sir David's appointment with AXA UK and Ireland, the Company does
not consider him to be independent.

 

Jill Anderson will join as an independent Non-Executive Director. Jill will
become a member of the Company's Audit and Risk Committee on appointment and
will become chair from 14 May 2025. She will also become a member of the
Remuneration Committee on appointment. Jill has 30 years' experience in the
healthcare sector, including executive responsibility in finance, commercial,
research and supply chain functions across large multinational organisations
principally with GSK plc. She is a trustee of Amref UK, an NGO focused on
healthcare in Africa, and was an associate non-executive director of London
Ambulance Service until 2022.

 

Sir Ian Cheshire, Spire Healthcare's Non-Executive Chairman, said:

 

"We are delighted that both Jill and Sir David have agreed to join Spire's
Board. The breadth of their expertise and experience in healthcare will be a
highly valuable addition to our Board and the Company. I look forward to
welcoming Sir David as the new chair of the Clinical Governance and Safety
Committee and Jill as the new chair of the Audit and Risk Committee.

 

"I would also like to thank Dame Janet for her considerable contribution to
Spire since the Company listed in 2014 and also Debbie White for chairing the
Audit and Risk Committee on an interim basis."

 

In accordance with the UK Listing Rules, there is no further information
required to be disclosed pursuant to UKLR 6.4.8R.

 

For further information please contact:

 

 Spire Healthcare                                                         investors@spirehealthcare.com

Amie Gramlick - Director of Investor Relations

 Instinctif Partners                                                      spire@instinctif.com

Julian Walker

 Tim Pearson

About Spire Healthcare

 

Spire Healthcare (http://www.spirehealthcare.com/) is the leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
 and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
 operations in the United Kingdom. It also delivers a range of private and
NHS mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.

 

Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUPUGWWUPAGMA